322 related articles for article (PubMed ID: 10192340)
1. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy.
Mandell LR; Kadota R; Freeman C; Douglass EC; Fontanesi J; Cohen ME; Kovnar E; Burger P; Sanford RA; Kepner J; Friedman H; Kun LE
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):959-64. PubMed ID: 10192340
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy for diffuse brainstem glioma in children and young adults.
Hu X; Fang Y; Hui X; Jv Y; You C
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD010439. PubMed ID: 27378212
[TBL] [Abstract][Full Text] [Related]
3. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study.
Freeman CR; Krischer JP; Sanford RA; Cohen ME; Burger PC; del Carpio R; Halperin EC; Munoz L; Friedman HS; Kun LE
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):197-206. PubMed ID: 8407392
[TBL] [Abstract][Full Text] [Related]
4. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial.
Packer RJ; Boyett JM; Zimmerman RA; Albright AL; Kaplan AM; Rorke LB; Selch MT; Cherlow JM; Finlay JL; Wara WM
Cancer; 1994 Sep; 74(6):1827-34. PubMed ID: 8082086
[TBL] [Abstract][Full Text] [Related]
5. UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group.
Lewis J; Lucraft H; Gholkar A
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):925-9. PubMed ID: 9276356
[TBL] [Abstract][Full Text] [Related]
6. Dose escalation using twice-daily radiotherapy for nasopharyngeal carcinoma: does heavier dosing result in a happier ending?
Jen YM; Lin YS; Su WF; Hsu WL; Hwang JM; Chao HL; Liu DW; Chen CM; Lin HY; Wu CJ; Chang LP; Shueng PW
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):14-22. PubMed ID: 12182970
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas.
Allen J; Siffert J; Donahue B; Nirenberg A; Jakacki R; Robertson P; DaRosso R; Thoron L; Rosovsky M; Pinto R
Cancer; 1999 Sep; 86(6):1064-9. PubMed ID: 10491535
[TBL] [Abstract][Full Text] [Related]
8. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study.
Bernier-Chastagner V; Grill J; Doz F; Bracard S; Gentet JC; Marie-Cardine A; Luporsi E; Margueritte G; Lejars O; Laithier V; Mechinaud F; Millot F; Kalifa C; Chastagner P
Cancer; 2005 Dec; 104(12):2792-7. PubMed ID: 16265674
[TBL] [Abstract][Full Text] [Related]
9. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
[TBL] [Abstract][Full Text] [Related]
10. Hyperfractionated radiotherapy for children with brainstem gliomas: a pilot study using 7,200 cGy.
Packer RJ; Allen JC; Goldwein JL; Newall J; Zimmerman RA; Priest J; Tomita T; Mandelbaum DE; Cohen BH; Finlay JL
Ann Neurol; 1990 Feb; 27(2):167-73. PubMed ID: 2317012
[TBL] [Abstract][Full Text] [Related]
11. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study.
Packer RJ; Prados M; Phillips P; Nicholson HS; Boyett JM; Goldwein J; Rorke LB; Needle MN; Sutton L; Zimmerman RA; Fitz CR; Vezina LG; Etcubanas E; Wallenberg JC; Reaman G; Wara W
Cancer; 1996 May; 77(10):2150-6. PubMed ID: 8640684
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
[TBL] [Abstract][Full Text] [Related]
13. Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults.
Shrieve DC; Wara WM; Edwards MS; Sneed PK; Prados MD; Cogen PH; Larson DA; Levin VA
Int J Radiat Oncol Biol Phys; 1992; 24(4):599-610. PubMed ID: 1429081
[TBL] [Abstract][Full Text] [Related]
14. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?
Freeman CR; Kepner J; Kun LE; Sanford RA; Kadota R; Mandell L; Friedman H
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):561-4. PubMed ID: 10837936
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study.
Walter AW; Gajjar A; Ochs JS; Langston JW; Sanford RA; Kun LE; Heideman R
Med Pediatr Oncol; 1998 Jan; 30(1):28-33. PubMed ID: 9371386
[TBL] [Abstract][Full Text] [Related]
16. Locoregionally advanced carcinoma of the oropharynx: conventional radiotherapy vs. accelerated hyperfractionated radiotherapy vs. concomitant radiotherapy and chemotherapy--a multicenter randomized trial.
Olmi P; Crispino S; Fallai C; Torri V; Rossi F; Bolner A; Amichetti M; Signor M; Taino R; Squadrelli M; Colombo A; Ardizzoia A; Ponticelli P; Franchin G; Minatel E; Gobitti C; Atzeni G; Gava A; Flann M; Marsoni S
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):78-92. PubMed ID: 12504039
[TBL] [Abstract][Full Text] [Related]
17. Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495.
Freeman CR; Krischer J; Sanford RA; Cohen ME; Burger PC; Kun L; Halperin EC; Crocker I; Wharam M
Cancer; 1991 Aug; 68(3):474-81. PubMed ID: 2065266
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
19. A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
Murray KJ; Scott C; Greenberg HM; Emami B; Seider M; Vora NL; Olson C; Whitton A; Movsas B; Curran W
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):571-4. PubMed ID: 9336134
[TBL] [Abstract][Full Text] [Related]
20. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
